Loading candles…
Morepen Laboratories Ltd is an Indian pharmaceutical company engaged in manufacturing, producing, developing, and marketing a broad range of pharmaceutical products. The company operates through several specialized business units and holds a significant position in the global active pharmaceutical ingredients (API) market. Its business segments include APIs, branded and generic formulations, home health products, medical devices (home diagnostics), and finished dosages. Morepen produces APIs including molecules such as Loratadine, Montelukast, and Atorvastatin. The company maintains manufacturing facilities that comply with international regulatory standards, including those of the USFDA. Though headquartered in India, its operations serve the global market. Morepen operates within the pharmaceuticals and medical devices industries.
This page is a live market overview for MOREPEN LAB. LTD (MOREPENLAB) on the NSE. As a listed security, MOREPEN LAB. LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for MOREPENLAB before placing trades on tick2trade.
As of the latest feed, MOREPENLAB last traded at ₹80.25 on NSE, up ₹0.83 (1.05%) from the previous close of ₹79.42. Today's session range is ₹78.92 – ₹82.89, against a 52-week band of ₹33.05 – ₹82.89. Traded volume today stands at 3.65Cr shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for MOREPENLAB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether MOREPENLAB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for MOREPEN LAB. LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in MOREPENLAB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated MOREPENLAB option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 4 Aug 2026 |
| Results - FY26 | MOREPENLAB : 26-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 22, 2026 has been re-scheduled. Further, the Company… | 26 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 10 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve un-audited standalone and consolidated financial results of the company for the quarter and half year ended 30th September 2025 | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | 6 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters | 12 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.